Camp4 Therapeutics (CAMP) Current Assets (2023 - 2026)

Camp4 Therapeutics' Current Assets history runs 4 years deep, the most recent figure standing at $102.2 million for Q1 2026.

• In Q1 2026, Current Assets rose 97.77% year-over-year to $102.2 million; the TTM figure through Mar 2026 stood at $102.2 million (up 97.77% YoY), while the FY2025 annual figure was $114.1 million, up 71.87% from the prior year.
• Current Assets came in at $102.2 million for Q1 2026 at Camp4 Therapeutics, down from $114.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $114.1 million in Q4 2025 to a low of $5.5 million in Q3 2024.
• A 4-year average of $62.3 million and a median of $59.0 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 65.9% in 2024 and surged 1311.85% in 2025, its largest moves.
• Camp4 Therapeutics' Current Assets stood at $40.0 million in 2023, then surged by 65.9% to $66.4 million in 2024, then surged by 71.87% to $114.1 million in 2025, then retreated by 10.43% to $102.2 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $102.2 million, $114.1 million, and $77.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison